ArticleScience China. Life sciences2026
Targeting KRAS reprograms a Treg-dominant immunosuppressive microenvironment and sensitizes KRAS-mutant gastric adenocarcinoma to CTLA-4 immunotherapy.
Xiaohuan Tang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.